New blood test could spot deadly liver cancer earlier, boosting survival chances
NCT ID NCT07265271
Summary
This study aims to develop a more accurate blood test to detect liver cancer (hepatocellular carcinoma) at its earliest stages. It will enroll 600 people with a confirmed liver cancer diagnosis to test a new method that looks for specific genetic signals in the blood. Finding cancer earlier is critical because it can lead to more effective treatment options and significantly better survival rates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.